Malee Warnnissorn

Malee Warnnissorn

Auto-generated profile, based on publicly available information

Malee Warnnissorn

Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
VPVitcha Poonyakanok
Vitcha Poonyakanok
MWMalee Warnnissorn
Malee Warnnissorn
PCPattama Chaopotong
Pattama Chaopotong

12 September 2013 in Case Reports in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
SHSuchanan Hanamornroongruang
Suchanan Hanamornroongruang
CNChanon Neungton
Chanon Neungton
MWMalee Warnnissorn
Malee Warnnissorn
Extramedullary hematopoiesis (EMH) is the presence of hematopoietic precursors outside the bone marrow. This condition is usually associated with hematologic disorders. Although EMH can be found in almost every site in the body, female genital tract involvement is rare. The authors report EMH in the uterine cervix from a 64-year-old patient following cervical biopsy due to abnormal cervical cytology. Neither neoplasm nor hematologic disorder was detected before the diagnosis and after 1 year of follow up. To the best of our knowledge, this is the first reported case of EMH involving the uterine cervix which showed an association with tissue repair.

24 July 2026 in Journal of Lower Genital Tract Disease
Verified
Journal Article
Closed access
PSPornphet Songsirithat
Pornphet Songsirithat
NJNida Jareemit
Nida Jareemit
MWMalee Warnnissorn
Malee Warnnissorn
STSuwanit Therasakvichya
Suwanit Therasakvichya
IRIrene Ruengkhachorn
Irene Ruengkhachorn
BVBoonlert Viriyapak
Boonlert Viriyapak
Objective: Pathologic diagnosis is essential for guiding the management of precancerous and cancerous cervical lesions. However, discrepancies between original and review pathology reports may significantly impact treatment decisions. This study aimed to evaluate the prevalence and associated factors of pathologic discrepancies in cervical lesions. Methods: This retrospective observational study included patients referred with a diagnosis of precancerous or cancerous cervical lesions between 2013 and 2023. Eligible cases required availability of both original and review pathology reports. Pathologic data from the original and review reports were retrospectively collected and compared. Discrepancies were categorized as major (those influencing treatment decisions or involving missing/critical information) or minor (those not impacting treatment). Clinical and pathologic variables, including turnaround times for the review process, were also analyzed. Results: A total of 376 cases were included. Specimens comprised biopsy/endocervical curettage (42.3%), conization (46.8%), and hysterectomy (10.9%). The mean patient age was 49.6 ± 12.9 years. Immunohistochemistry was used in 4% of original and 4.3% of review examinations. The median review turnaround time was 3 days (IQR, 1 to 6), extended to 6 days (IQR, 4.3 to 12) when additional immunohistochemistry was required. Overall, 58.2% of cases demonstrated discrepancies: 33.2% major and 25% minor. The 3 most common major discrepancies were changes in pathologic diagnosis, lymphovascular space invasion, and tumor size. Multivariable analysis showed no clinical factors associated with major discrepancies. Conclusion: Pathology review revealed a high rate of discrepancies in cervical lesions, with significant clinical implications. Mandatory review is warranted for preinvasive and invasive cervical lesions.